Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Hashimoto

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Scientific Reports|March 26, 2022
Kinetics of LYVE-1-positive M2-like macrophages in developing and repairing dental pulp in vivo and their pro-angiogenic activity in vitroThoai Quoc Kieu, Kento Tazawa, Nobuyuki Kawashima, et al.
Biochemical and Biophysical Research Communications|November 27, 2019
HIF1α inhibits LPS-mediated induction of IL-6 synthesis via SOCS3-dependent CEBPβ suppression in human dental pulp cellsMayuko Fujii, Nobuyuki Kawashima, Kento Tazawa, et al.
Biochemical and Biophysical Research Communications|November 6, 2016
An inhibitor of apoptosis protein antagonist T-3256336 potentiates the antitumor efficacy of the Nedd8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924)Hiroyuki Sumi, Masakazu Inazuka, Megumi Morimoto, et al.
Chemical & Pharmaceutical Bulletin|October 6, 2005
Benzimidazole-5-sulfonamides as novel nonpeptide luteinizing hormone releasing hormone (LHRH) antagonists: minimization of mechanism-based CYP3A4 inhibitionKentaro Hashimoto, Mikayo Kataoka, Miyuki Tatsuta, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 2: Benzimidazole-5-sulfonamidesYingfu Li, Mikayo Kataoka, Miyuki Tatsuta, et al.
Clinical and Translational Science|August 1, 2025
Pharmacokinetics of Bocidelpar, ASP0367, in Renal and Hepatic Impairment: Results From Two Phase 1 StudiesMegumi Iwai, Nakyo Heo, Kentaro Hashimoto, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 1: Benzimidazole-5-sulfonamidesKentaro Hashimoto, Miyuki Tatsuta, Mikayo Kataoka, et al.
BMC Cancer|March 4, 2025
Safety and efficacy of pemetrexed for patients with non-small cell lung cancer in the setting of renal impairment: a retrospective studyYusuke Shima, Hironori Yoshida, Keiichiro Suminaga, et al.
Eneurologicalsci|June 12, 2025
A case of fragile X-associated tremor/ataxia syndrome with superior cerebellar peduncle lesionsKunihiko Ishizawa, Kentaro Hashimoto, Hironori Oka, et al.
Oncology Letters|October 24, 2022
Sarcomatoid malignant pleural mesothelioma treated with nivolumab: A case seriesKentaro Hashimoto, Hiroaki Ozasa, Akihiko Yoshizawa, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Scientific Reports|March 26, 2022
Kinetics of LYVE-1-positive M2-like macrophages in developing and repairing dental pulp in vivo and their pro-angiogenic activity in vitroThoai Quoc Kieu, Kento Tazawa, Nobuyuki Kawashima, et al.
Biochemical and Biophysical Research Communications|November 27, 2019
HIF1α inhibits LPS-mediated induction of IL-6 synthesis via SOCS3-dependent CEBPβ suppression in human dental pulp cellsMayuko Fujii, Nobuyuki Kawashima, Kento Tazawa, et al.
Biochemical and Biophysical Research Communications|November 6, 2016
An inhibitor of apoptosis protein antagonist T-3256336 potentiates the antitumor efficacy of the Nedd8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924)Hiroyuki Sumi, Masakazu Inazuka, Megumi Morimoto, et al.
Chemical & Pharmaceutical Bulletin|October 6, 2005
Benzimidazole-5-sulfonamides as novel nonpeptide luteinizing hormone releasing hormone (LHRH) antagonists: minimization of mechanism-based CYP3A4 inhibitionKentaro Hashimoto, Mikayo Kataoka, Miyuki Tatsuta, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 2: Benzimidazole-5-sulfonamidesYingfu Li, Mikayo Kataoka, Miyuki Tatsuta, et al.
Clinical and Translational Science|August 1, 2025
Pharmacokinetics of Bocidelpar, ASP0367, in Renal and Hepatic Impairment: Results From Two Phase 1 StudiesMegumi Iwai, Nakyo Heo, Kentaro Hashimoto, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 1: Benzimidazole-5-sulfonamidesKentaro Hashimoto, Miyuki Tatsuta, Mikayo Kataoka, et al.
BMC Cancer|March 4, 2025
Safety and efficacy of pemetrexed for patients with non-small cell lung cancer in the setting of renal impairment: a retrospective studyYusuke Shima, Hironori Yoshida, Keiichiro Suminaga, et al.
Eneurologicalsci|June 12, 2025
A case of fragile X-associated tremor/ataxia syndrome with superior cerebellar peduncle lesionsKunihiko Ishizawa, Kentaro Hashimoto, Hironori Oka, et al.
Oncology Letters|October 24, 2022
Sarcomatoid malignant pleural mesothelioma treated with nivolumab: A case seriesKentaro Hashimoto, Hiroaki Ozasa, Akihiko Yoshizawa, et al.
Pageof 5